EPM speaks to Chris Ross, head of Life Science Integrated Supply Chain Operations at Merck to discuss the company's response to Covid-19 and the challenges in developing and supplying vaccines.
EPM speaks to Kevin Deane, vice president of Front-End Innovation and Connected Health at. Phillips-Medisize about the promise of connected health in drug delivery for patients, pharmaceutical providers, and the healthcare industry.
Ian Bolland speaks to Epistemic AI founders Stefano Pacifico and David Heeger about how its software can be used in drug development and the race to find a cure for Coronavirus.
Ursula Nollenberger, product line director and Kevin Ehlert, segment manager, Trelleborg Healthcare & Medical discuss the necessary steps to launching a succesful drug/device combination product.
EPM speaks to Alex Guite, vice president of Services and Alliances at World Courier about the impact Covid-19 has had on the clinical trials sector and how a direct-to-patient approach can help trials continue.
David Knight, partner and Joshua Marshall, senior associate at Fieldfisher discuss the implications the Covid-19 Technology Access Pool is having on innovation in pharma.
European Pharmaceutical Manufacturer editor Reece Armstrong looks at the issue of diversity in clinical trials and how medicines aren't developed with every patient in mind.
Pari Sanghavi, senior director, life sciences supply chain and manufacturing at Cognizant and Jim Lehane, global leader business development at Zenith discuss how manufacturing must change following Covid-19.
EPM speaks to Jean-Pierre Joubert, product manager at CN Bio Innovations who talks about his journey into biotech, the challenges of drug development, and why opportunities come from unlikely places.
EPM sits down with Scott Ross, global product specialist for the GORE LYOGUARD Freeze-Drying Trays, to learn about lyophilsation in API manufacturing and the benefits of single-use products.
